Quarter Financials
Relmada Therapeutics, Inc. (RLMD)
$2.6
-0.21 (-7.47%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| Net Income | -26 | -38 | -39 | -40 | -40 | -34 | -43 | -27 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -488 | -462 | -424 | -385 | -345 | -305 | -271 | -228 |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | - | - | - | - | - | - | - | - |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
|---|
| New Purchases | -36 | -26 | -141 | -26 | -7 | -6 | -8 | -35 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|